13D Filing: Glaxosmithkline Plc and Htg Molecular Diagnostics Inc (NASDAQ:HTGM)

11.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

792,781 shares of Common Stock (1)

12.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions) ☐

13.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

9.8% of the shares of Common Stock (2)

14.

TYPE OF REPORTING PERSON (see instructions)

CO

Footnotes:

(1) Shares of Common Stock are held of record by S.R. One, Limited, an indirect, wholly-owned subsidiary of the Reporting Person.

(2) Based on 8,052,451 shares of Common Stock outstanding as of March 17,
2017.


1.		NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) GlaxoSmithKline plc
2.		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ☐ (b) ☐
3.		SEC USE ONLY
4.		SOURCE OF FUNDS (see instructions) WC
5.		CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ☐
6.		CITIZENSHIP OR PLACE OF ORGANIZATION England and Wales


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7.	SOLE VOTING POWER 792,781
	8.	SHARED VOTING POWER -0-
	9.	SOLE DISPOSITIVE POWER 792,781
	10.	SHARED DISPOSITIVE POWER -0-

Page 2 of 7 – SEC Filing